Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
6.09
-0.01 (-0.16%)
At close: Oct 15, 2025, 4:00 PM EDT
5.98
-0.11 (-1.81%)
After-hours: Oct 15, 2025, 5:39 PM EDT
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $229.07 million as of October 15, 2025. Its market cap has decreased by -26.44% in one year.
Market Cap
229.07M
Enterprise Value
205.13M
1-Year Change
-26.44%
Ranking
Category
Stock Price
$6.09
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $229.07M, a decrease of -54.74%. That is a compound annual growth rate of -15.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 232.13M | -27.47% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
| Feb 9, 2021 | 506.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.83B |
| Johnson & Johnson | 459.44B |
| AbbVie | 410.25B |
| UnitedHealth Group | 324.03B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 260.80B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 229.31B |